AESKULISAAESKULISA® Rheumatology Test Kits
FDA cleared Products


Connective tissue diseases are systemic autoimmune diseases including SLE, scleroderma, polymyositis/dermatomyositis, mixed connective tissue diseases (MCTD) and Sjögren’s syndrome.

In Rheumatoid arthritis (RA) mainly the joints and associated structures are affected. Early diagnosis and prognosis of RA are essential to prevent irreversible joint destruction.

AESKU® Rheumatology line offers a complete panel of routine and research usage kits, including more than 40 different parameters.

 

Reference
Description
Kit Config
Antibodies
Quant.
Qual.
Cut Off
Range
Standard

ANA-HEp2 (FDA cleared)
Single-G
IgG
Quant.
Qual.
Calib.
0-300 U/ml
CDC
dsDNA-G (FDA cleared)
Single-G
IgG
Quant.
Qual.
15
0-300 U/ml
WHO
Wo/80
ANA-8Pro (FDA cleared)
Profile-G
IgG
Qual.
Calib.
-
CDC
ENA-6S (FDA cleared)
Screening-G
IgG
Qual.
Calib.
-
CDC
ENA-6Pro (FDA cleared)
Profile-G
IgG
Semi
Quant.
15
0-100
U/ml
CDC
U1-70 (FDA cleared)
Single-G
IgG
Quant.
Qual.
15
0-300
U/ml
CDC
snRNP-C (FDA cleared)
Single-G
IgG
Quant.
Qual.
15
0-300
U/ml
CDC
Sm (FDA cleared)
Single-G
IgG
Quant.
Qual.
15
0-300
U/ml
CDC
SS-A (FDA cleared)
Single-G
IgG
Quant.
Qual.
15
0-300
U/ml
CDC
SS-B (FDA cleared)
Single-G
IgG
Quant.
Qual.
15
0-300
U/ml
CDC
Scl-70 (FDA cleared)
Single-G
IgG
Quant.
Qual.
15
0-300
U/ml
CDC
Cenp-B (FDA cleared)
Single-G
IgG
Quant.
Qual.
15
0-300
U/ml
CDC
Jo-1 (FDA cleared)
Single-G
IgG
Quant.
Qual.
15
0-300
U/ml
CDC